Our Services
Comprehensive Valuation Solutions
From 409A valuations to complex securities and purchase price allocations, we deliver audit-ready reports using industry-leading methodologies tailored to your specific engagement needs.
01
Financial Reporting Valuations
Comprehensive fair market value assessments for startup equity compensation. We provide defensible valuations using appropriate methodologies (market approach, income approach, asset approach) that satisfy IRS requirements and support your clients' stock option plans.
Fair value measurements for all types of equity compensation including stock options, restricted stock units (RSUs), performance shares, and employee stock purchase plans. Our models account for market conditions, service conditions, and performance conditions.
Identification and valuation of acquired intangible assets in business combinations including customer relationships, technology, trade names, non-compete agreements, and goodwill. Full compliance with ASC 805 and IFRS 3 requirements.
Quarterly and annual fair value measurements for PE/VC fund portfolios. We apply the ASC 820 fair value hierarchy, utilizing Level 1, 2, and 3 inputs as appropriate, with comprehensive documentation for audit support.
Assess the recoverability of goodwill and long-lived assets to support periodic impairment testing requirements.
02
Tax & Compliance Valuations
Arm's length valuations for intercompany transactions including IP transfers, cost-sharing arrangements, and service agreements to support transfer pricing documentation and compliance.
03
Complex Securities & Derivatives
Valuation of convertible instruments accounting for conversion features, discount rates, valuation caps, and qualifying financing triggers using option pricing models and scenario analysis.
Black-Scholes, binomial lattice, and Monte Carlo simulation models for warrant and option valuation, incorporating exercise conditions, vesting schedules, and early exercise behavior.
Probability-weighted and option-based approaches for valuing contingent payments in M&A transactions, addressing revenue milestones, EBITDA targets, and other performance-based triggers.
04
Valuation Techniques
Income approach valuations utilizing multi-stage DCF models with appropriate discount rates derived from CAPM, build-up methods, or WACC frameworks tailored to the subject company's risk profile.
Market approach valuations using carefully selected peer groups with relevant valuation multiples (EV/Revenue, EV/EBITDA, P/E) adjusted for size, growth, profitability, and risk differences.
Estimate value using valuation multiples derived from comparable mergers and acquisition transactions.
Estimate value based on the cost required to recreate or replace an asset, adjusted for physical, functional, and economic obsolescence.
Estimate the value of pharmaceutical and biotechnology assets by adjusting projected cash flows for the probability of successfully achieving clinical, regulatory, and commercial milestones throughout the drug development lifecycle.
05
Allocation Methods
Allocation of equity value across share classes treating each class as a call option on the enterprise value, incorporating liquidation preferences, participation rights, and conversion features.
Scenario-based allocation method modeling multiple future outcomes (IPO, M&A, dissolution) with assigned probabilities to determine current values of each equity class.
Allocation based on current liquidation value of the enterprise, typically appropriate for companies near a liquidity event or with limited growth expectations.
Value options and option-like instruments using factors such as volatility, exercise price, term, and risk-free rate.
Model a large number of potential future outcomes to value complex securities and contingent claims.
06
PPA Techniques
Income-based approach for valuing primary intangible assets by isolating their contributory earnings after deducting charges for other supporting assets, commonly used for customer relationships.
Valuation of intellectual property (technology, trade names) by estimating the royalty savings achieved through ownership rather than licensing the asset from a third party.
Valuation approach comparing the enterprise value with the subject intangible asset versus without it, quantifying the incremental value attributable to the specific asset.
Cost approach for intangible asset valuation estimating the cost to recreate or replace the asset, adjusted for functional and economic obsolescence, including developer costs and opportunity costs.
By The Numbers
Our Track Record
0+
Valuations Completed
0+
Industries Covered
0+
Methodologies
0-7 Days
Typical Project Turnaround
0%
Audit Pass Rate
Need a Specific Valuation?
Tell us about your engagement requirements and we'll propose the right approach.
Discuss Your Needs